Novel insights into APOL1
Time: 9:00 am
day: Day One
Details:
- Overview of Natera’s unique real-world clinicogenomic database; the backbone of which is the Renasight™ test, which interrogates kidney diseases at the molecular level
- Novel insights into APOL1 through retrospective correlation analysis of ~40,000 patients
